ABCA4 Variant c.5714+5G>A in Trans With Null Alleles Results in Primary RPE Damage.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
medline:
22
9
2023
pubmed:
20
9
2023
entrez:
20
9
2023
Statut:
ppublish
Résumé
To determine the disease pathogenesis associated with the frequent ABCA4 variant c.5714+5G>A (p.[=,Glu1863Leufs*33]). Patient-derived photoreceptor precursor cells were generated to analyze the effect of c.5714+5G>A on splicing and perform a quantitative analysis of c.5714+5G>A products. Patients with c.5714+5G>A in trans with a null allele (i.e., c.5714+5G>A patients; n = 7) were compared with patients with two null alleles (i.e., double null patients; n = 11); with a special attention to the degree of RPE atrophy (area of definitely decreased autofluorescence and the degree of photoreceptor impairment (outer nuclear layer thickness and pattern electroretinography amplitude). RT-PCR of mRNA from patient-derived photoreceptor precursor cells showed exon 40 and exon 39/40 deletion products, as well as the normal transcript. Quantification of products showed 52.4% normal and 47.6% mutant ABCA4 mRNA. Clinically, c.5714+5G>A patients displayed significantly better structural and functional preservation of photoreceptors (thicker outer nuclear layer, presence of tubulations, higher pattern electroretinography amplitude) than double null patients with similar degrees of RPE loss, whereas double null patients exhibited signs of extensive photoreceptor ,damage even in the areas with preserved RPE. The prototypical STGD1 sequence of events of primary RPE and secondary photoreceptor damage is congruous with c.5714+5G>A, but not the double null genotype, which implies different and genotype-dependent disease mechanisms. We hypothesize that the relative photoreceptor sparing in c.5714+5G>A patients results from the remaining function of the ABCA4 transporter originating from the normally spliced product, possibly by decreasing the direct bisretinoid toxicity on photoreceptor membranes.
Identifiants
pubmed: 37728905
pii: 2792769
doi: 10.1167/iovs.64.12.33
pmc: PMC10516765
doi:
Substances chimiques
RNA, Messenger
0
ABCA4 protein, human
0
ATP-Binding Cassette Transporters
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Références
Retina. 2018 Aug;38(8):1518-1525
pubmed: 28837535
Ophthalmology. 2018 Jan;125(1):89-99
pubmed: 28947085
Adv Exp Med Biol. 2010;703:105-25
pubmed: 20711710
Genes (Basel). 2021 Aug 13;12(8):
pubmed: 34440414
Transl Vis Sci Technol. 2021 Jan 05;10(1):3
pubmed: 33505770
Sci Rep. 2016 Oct 14;6:35414
pubmed: 27739528
Retina. 2013 Oct;33(9):1871-6
pubmed: 23676993
Ophthalmology. 2019 Dec;126(12):1712-1721
pubmed: 31522899
Exp Eye Res. 2009 Jun 15;89(1):16-24
pubmed: 19217903
Mol Ther Nucleic Acids. 2020 Sep 4;21:412-427
pubmed: 32653833
Am J Hum Genet. 1999 Apr;64(4):1024-35
pubmed: 10090887
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):5024-9
pubmed: 24707049
Arch Ophthalmol. 1976 Dec;94(12):2061-7
pubmed: 999551
Hum Mol Genet. 1998 Mar;7(3):355-62
pubmed: 9466990
Genet Med. 2020 Jul;22(7):1235-1246
pubmed: 32307445
Eur J Hum Genet. 2020 Jul;28(7):925-937
pubmed: 32467599
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):5029-39
pubmed: 26230768
Nat Genet. 2000 Jul;25(3):257-8
pubmed: 10888868
Br J Ophthalmol. 2019 Mar;103(3):390-397
pubmed: 29925512
Am J Hum Genet. 2022 Mar 3;109(3):498-507
pubmed: 35120629
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7467-78
pubmed: 25324290
Exp Eye Res. 1976 Aug;23(2):105-15
pubmed: 976361
Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90
pubmed: 24265018
Hum Mol Genet. 2005 Oct 1;14(19):2769-78
pubmed: 16103129
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5186-5191
pubmed: 27699414
Nat Genet. 1997 Sep;17(1):15-6
pubmed: 9288089
Ophthalmology. 2012 Mar;119(3):596-605
pubmed: 22182799
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4668-78
pubmed: 27583828
Ophthalmology. 2017 Sep;124(9):1353-1367
pubmed: 28456420
Invest Ophthalmol Vis Sci. 2012 Jul 03;53(8):4458-67
pubmed: 22661473
Prog Retin Eye Res. 2013 Nov;37:114-40
pubmed: 23994436
Ophthalmology. 2013 Nov;120(11):2332-7
pubmed: 23755871
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Med Genet. 2017 Jun;54(6):404-412
pubmed: 28446513
Sci Rep. 2021 Jul 19;11(1):14735
pubmed: 34282240
Doc Ophthalmol. 2022 Jun;144(3):165-177
pubmed: 35511377
Genome Res. 2018 Jan;28(1):100-110
pubmed: 29162642
Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13
pubmed: 23499370
Biochim Biophys Acta. 2009 Jul;1791(7):573-83
pubmed: 19230850
Genes (Basel). 2019 Nov 21;10(12):
pubmed: 31766579
Int J Mol Sci. 2020 May 13;21(10):
pubmed: 32413971
JAMA Ophthalmol. 2019 Oct 01;137(10):1134-1145
pubmed: 31369039
Ophthalmology. 2015 Feb;122(2):335-44
pubmed: 25444351
Prog Retin Eye Res. 2020 Nov;79:100861
pubmed: 32278709
Am J Ophthalmol. 2020 Nov;219:195-204
pubmed: 32619608
Ophthalmology. 2016 Jun;123(6):1375-85
pubmed: 26976702
Transl Vis Sci Technol. 2020 Jun 25;9(7):33
pubmed: 32832238
Ophthalmol Clin North Am. 2002 Mar;15(1):93-100, viii
pubmed: 12064087
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11120-E11127
pubmed: 30397118
Transl Vis Sci Technol. 2016 Mar 11;5(2):6
pubmed: 26981328
Stem Cell Res. 2022 Apr;60:102669
pubmed: 35063911
J Biol Chem. 1997 Apr 11;272(15):10303-10
pubmed: 9092582
Arch Ophthalmol. 2001 Mar;119(3):359-69
pubmed: 11231769
JCI Insight. 2022 Jan 25;7(2):
pubmed: 34874912
Br J Ophthalmol. 2017 Jan;101(1):25-30
pubmed: 27491360
Invest Ophthalmol Vis Sci. 2016 Nov 01;57(14):5963-5973
pubmed: 27820952
Ophthalmic Genet. 2011 Sep;32(3):165-74
pubmed: 21510770
Nat Genet. 2000 Oct;26(2):242-6
pubmed: 11017087
Genet Med. 2019 Aug;21(8):1751-1760
pubmed: 30643219
Am J Ophthalmol. 2020 Mar;211:159-175
pubmed: 31812472
Retina. 2008 Oct;28(9):1234-40
pubmed: 18628727
Hum Genet. 1986 Aug;73(4):320-6
pubmed: 3017841
Am J Hum Genet. 2018 Apr 5;102(4):517-527
pubmed: 29526278
Doc Ophthalmol. 2013 Feb;126(1):1-7
pubmed: 23073702
Am J Ophthalmol. 2013 Sep;156(3):487-501.e1
pubmed: 23953153
J Ophthalmol. 2018 Apr 30;2018:5706142
pubmed: 29854428
Cell. 1999 Jul 9;98(1):13-23
pubmed: 10412977